8th annual report: Down year for launches
In a challenging 2009 for products with $100+ million in sales during their first full year
of U.S. availability, UCB stood out with two new drug introductions and was joined by
GlaxoSmithKline, Astellas, and Cephalon as marketers of relatively successful newcomers.
By Steven Niles
Long-range transmission
Marketers must strike a careful balance between centralized and localized control and maintain
a consistent message across cultures, regions, and regulatory regimes when managing global
brands..
By Joshua Slatko
Follow that sample
Pharmaceutical companies are already taking into account the impact that the federal
requirement to report sampling will have.
By Colette Pilkus
Simplify and fortify
Pharmaceutical marketers have an important role to play in easing the information overload
burdening oncology professionals and patients.
By Gina-Louise Monari
Sales & marketing
Teva Pharmaceutical Industries Ltd. has admitted that the physician prescribing information included with packages of
Gianvi did falsely claim that the ethinyl estradiol in the product was stabilized by Bayer’s patented “betadex as a clathrate”
formulation.
By Joshua Slatko
Business
Major pharmaceutical and biotechnolgy companies are moving their emerging markets strategies forward in regions as
diverse as South America, South Africa, and South Korea.
By Steven Niles
The Leader's Edge: Can we text?
Sander Flaum, managing partner, Flaum Partners, discusses why today’s leaders must be aware of the changes in
communication and the impact it is having on business today.
By Sander Flaum
People on the Move
Bausch + Lomb is investing in leadership within its surgical division and Asia-Pacific region.
By Gina-Louise Monari
Ad Agency Update
Grey Healthcare Group is ramping up its digital resources with the launch of a Digital Health Assessment tool.
By Gina-Louise Monari
Pitch Therapy: All Hands on Deck
Mark Schnurman, pitch consultant and founder of Filament Inc., lays out the pros and cons of the two philosophies of
deck writing.
By Mark Schnurman, pitch consultant and founder of Filament Inc.
Interactive & digital marketing
The U.S. Department of Health and Human Services has launched a new online tool that aims to help consumers take
control of their healthcare by connecting them to new information and resources that will help them access quality,
affordable healthcare coverage.
By Joshua Slatko
FDA Focus
FDA has unveiled a new source of information for patients and healthcare professionals regarding the safety of recently
approved drugs and biologics.
By Steven Niles
Drug Approvals
Following priority reviews, FDA has approved two cancer drugs: Novartis’ Tasigna for newly diagnosed Philadelphia
chromosome-positive chronic myeloid leukemia patients and Sanofi-Aventis’ Jevtana for advanced hormone-refractory
prostate cancer.
By Gina-Louise Monari
Oncology Market Soars in China
Multinational companies are gaining
momentum with new, targeted
therapies.
By Steven Gavel, global marketing director, Oncology, Product and Portfolio Management, IMS Health
Packaging enhances the
Toviaz experience
Pfizer Inc.’s packaging for Toviaz
ensures a more comprehensive
and secure brand experience on
behalf of patients and healthcare
professionals.
By Gina-Louise Monari
Get qualitative analysis of pharmaceutical, biotechnology, and medical device companies’ product portfolios and market share in the vaccines market. Our experts provide insight into areas of opportunity, successful discovery and R&D strategies, and drugs/delivery systems in development. PURCHASE NOW – SAVE $70!